411 related articles for article (PubMed ID: 15998776)
1. Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function.
Marthinet E; Bloc A; Oka Y; Tanizawa Y; Wehrle-Haller B; Bancila V; Dubuis JM; Philippe J; Schwitzgebel VM
J Clin Endocrinol Metab; 2005 Sep; 90(9):5401-6. PubMed ID: 15998776
[TBL] [Abstract][Full Text] [Related]
2. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy.
Cartier EA; Conti LR; Vandenberg CA; Shyng SL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2882-7. PubMed ID: 11226335
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a novel member of the ATP-sensitive K+ channel subunit family, Kir6.3, in zebrafish.
Zhang C; Miki T; Shibasaki T; Yokokura M; Saraya A; Seino S
Physiol Genomics; 2006 Feb; 24(3):290-7. PubMed ID: 16317080
[TBL] [Abstract][Full Text] [Related]
4. Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels.
Taschenberger G; Mougey A; Shen S; Lester LB; LaFranchi S; Shyng SL
J Biol Chem; 2002 May; 277(19):17139-46. PubMed ID: 11867634
[TBL] [Abstract][Full Text] [Related]
5. Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism.
Lin YW; Bushman JD; Yan FF; Haidar S; MacMullen C; Ganguly A; Stanley CA; Shyng SL
J Biol Chem; 2008 Apr; 283(14):9146-56. PubMed ID: 18250167
[TBL] [Abstract][Full Text] [Related]
6. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism.
Partridge CJ; Beech DJ; Sivaprasadarao A
J Biol Chem; 2001 Sep; 276(38):35947-52. PubMed ID: 11457841
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.
Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL
J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370
[TBL] [Abstract][Full Text] [Related]
8. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.
Yan FF; Lin YW; MacMullen C; Ganguly A; Stanley CA; Shyng SL
Diabetes; 2007 Sep; 56(9):2339-48. PubMed ID: 17575084
[TBL] [Abstract][Full Text] [Related]
9. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
[TBL] [Abstract][Full Text] [Related]
10. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.
Otonkoski T; Ammälä C; Huopio H; Cote GJ; Chapman J; Cosgrove K; Ashfield R; Huang E; Komulainen J; Ashcroft FM; Dunne MJ; Kere J; Thomas PM
Diabetes; 1999 Feb; 48(2):408-15. PubMed ID: 10334322
[TBL] [Abstract][Full Text] [Related]
11. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy.
Shyng SL; Ferrigni T; Shepard JB; Nestorowicz A; Glaser B; Permutt MA; Nichols CG
Diabetes; 1998 Jul; 47(7):1145-51. PubMed ID: 9648840
[TBL] [Abstract][Full Text] [Related]
12. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.
Hosy E; Dérand R; Revilloud J; Vivaudou M
J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180
[TBL] [Abstract][Full Text] [Related]
13. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
[TBL] [Abstract][Full Text] [Related]
14. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.
Huopio H; Reimann F; Ashfield R; Komulainen J; Lenko HL; Rahier J; Vauhkonen I; Kere J; Laakso M; Ashcroft F; Otonkoski T
J Clin Invest; 2000 Oct; 106(7):897-906. PubMed ID: 11018078
[TBL] [Abstract][Full Text] [Related]
15. Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels.
Yan FF; Lin CW; Cartier EA; Shyng SL
Am J Physiol Cell Physiol; 2005 Nov; 289(5):C1351-9. PubMed ID: 15987767
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of new KATP-channel mutations associated with congenital hyperinsulinism in the Finnish population.
Reimann F; Huopio H; Dabrowski M; Proks P; Gribble FM; Laakso M; Otonkoski T; Ashcroft FM
Diabetologia; 2003 Feb; 46(2):241-9. PubMed ID: 12627323
[TBL] [Abstract][Full Text] [Related]
17. Complex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies.
Muzyamba M; Farzaneh T; Behe P; Thomas A; Christesen HB; Brusgaard K; Hussain K; Tinker A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):115-24. PubMed ID: 17466004
[TBL] [Abstract][Full Text] [Related]
18. In vitro recovery of ATP-sensitive potassium channels in β-cells from patients with congenital hyperinsulinism of infancy.
Powell PD; Bellanné-Chantelot C; Flanagan SE; Ellard S; Rooman R; Hussain K; Skae M; Clayton P; de Lonlay P; Dunne MJ; Cosgrove KE
Diabetes; 2011 Apr; 60(4):1223-8. PubMed ID: 21411514
[TBL] [Abstract][Full Text] [Related]
19. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
[TBL] [Abstract][Full Text] [Related]
20. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
